Color announces layoffs as it rolls back COVID-19 testing

1 minute, 41 seconds Read

[ad_1]

Populace health engineering corporation Coloration declared it had laid off workers as it pivots focus away from COVID-19 screening.

According to posts by previous workforce on LinkedIn, the enterprise slash 300 positions. Color CEO Othman Laraki confirmed the layoffs in his individual post, saying the corporation was downsizing its groups centered on COVID-19 tests presented the looming finish of the public wellness emergency and lessened shopper curiosity in pandemic-similar companies. 

Laraki claimed the organization would target on its testing and telehealth infrastructure for federal government plans, and also its prevention tools for companies and healthcare purchasers.

“Amidst adjust, we will proceed to support existing programs and maximize entry for underserved populations. With a reinvestment in our main small business and the rely on of our consumers, we are concentrated on delivering large accessibility, significant effects population healthcare packages that aid every person direct the healthiest everyday living that science and medication can provide. Although yesterday was a complicated working day for our crew, we are optimistic about our future as a corporation and the effect we will have,” he wrote.

THE Larger sized Development

Colour raised two significant rounds of funding in 2021, which include a $167 million Collection D and a $100 million Series E. The firm, which earlier centered on genomics right before pivoting to community wellbeing tech, added behavioral well being expert services with the acquisition of Mood Lifters past calendar year.

Layoffs at electronic overall health and wellness tech companies surged in 2022, which include at startups that had lifted sizeable quantities of trader dollars in 2021.

A declining target on COVID-19 has also impacted some organizations. Lucira Overall health, which develops residence diagnostic assessments, a short while ago submitted for bankruptcy just as the company been given the very first Crisis Use Authorization from the Food and drug administration for an above-the-counter at-property blend COVID-19 and flu take a look at. The enterprise said the regulatory process had taken for a longer time than it predicted and desire for its COVID-19 checks had slowed in 2022.

[ad_2]

Source hyperlink

Similar Posts